FOXC1 and gastric cancer: Collectively, our experimental data demonstrated that LINC00242 knockdown exerted anti-tumor effects in GC by inhibiting malignant cell growth, migration, invasion and angiogenesis through miR-141 target-inhibition of FOXC1 (Fig. 6).